InCrowd Industry Highlights for Pharma Market Researchers:

This edition highlights five of the most promising drugs for 2013, why putting social listening to work is beneficial, insight into the pricing behind a $300,000-a-year drug, needed pharma business model adjustments, and the sector outlook from the JPMorgan Healthcare Conference:

– The FDA gave approvals to 39 new drugs last year (the highest number since the mid-1990s) and regulators are on track to approve as many as 36 novel drug compounds able to generate U.S. sales of $9 billion in 2018. Barron’s 5 Blockbuster Drugs for 2013 covers their list of five of the most promising new drugs for 2013 along with their top-line potential

– Listening to social conversation can actually help you enact meaningful changes that positively impact your business – and your bottom line. Healthcare Marketing: Social Listening + Predictive Analysis from Business 2 Community offers examples on how social listening can help you predict sales fluctuations and optimize your business accordingly

– NPS Pharmaceuticals announced that it was pricing Gattex at $295,000 per patient per year, the fourth drug approved in 2012 to be priced at more than $200,000 per patient per year. Forbes Pricing Of A $300,000-A-Year Drug highlights 5 key bullet points reflecting NPS’ reasons for pricing the drug as it did

– “Pharma’s fight for profitability” study by Roland Berger Strategy Consultants reveals Global Pharmaceutical industry is in a Strategic Crisis – Business Models Must be Adjusted and identifies four possible strategic approaches that can help the pharmaceutical industry optimally position itself in various markets with a diverse range of solutions

-Asking the question Ryan: Is the Health Care Sector ‘Healthy?’ during the Annual JPMorgan Healthcare Conference offers a mixed message and sets the tone for the sector’s outlook

That wraps this week’s review of news from and for the pharma market research community. I’ll leave you with an invitation to learn more about the benefits of real time data and offer you a personal demo of InCrowd’s on-demand platform providing you direct and immediate access to Crowds of screened and targeted healthcare professionals.

If you have tips, suggestions, or resources you’d like to share leave us a comment below and please feel free to suggest topics that you would like to see covered in future posts.